Zhang Jin-San, Dhlamini Qhaweni, Guo Qiang, Quan Meiyu, Wu Jin, Lyu Handeng, Chong Lei, Lv Yuqing, Lin Yuting, Zhou Bin, Liu Yuru, Ji Honglong, Lin Xinhua, Ning Wen, Sui Pengfei, Chen Huaiyong, Gao Peisong, Chen Wei, Zhou Xiaobo, Song Yuanlin, Wang Chaoqun, Su Xiao, Xu Jinfu, Sun Jie, Chen Yin, Geng Yan, Song Hai, Ji Hongbin, Di Yuanpu Peter, Tang Hao, Lu Chao, Li Jinghong, Cheng Ke, Cao Mengshu, Liang Jiurong, Zhang Yingze, Zhou Yang, Xi Ying, Xiong Weining, Cao Bin, Que Jianwen, Jiang Dianhua
Zhejiang Key Laboratory of Interventional Pulmonology, and Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
The State Key Laboratory of Cell Biology, CAS Center for Excellence on Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
J Respir Biol Transl Med. 2024;1(4). doi: 10.70322/jrbtm.2024.10021. Epub 2024 Dec 4.
Respiratory diseases pose a major public health challenge globally, necessitating collaborative efforts between basic researchers and clinicians for effective solutions. China, which is heavily impacted by a broad spectrum of respiratory disorders, has made notable strides in both research and clinical management of these diseases. The International Respiratory Medicine (IRM) meeting was organized with the primary goal of facilitating the exchange of recent research developments and promoting collaboration between Chinese and American scientists in both basic and clinical research fields. This article summarizes key insights from IRM2024, held in Shanghai, where a wide range of topics were discussed, including lung tissue development, disease mechanisms, and innovative therapeutic strategies. By integrating perspectives from basic, translational, and clinical research, IRM2024 highlighted recent advancements, addressed persistent challenges, and explored future directions in respiratory science and clinical practice. The insights gained from IRM2024 are poised to be pivotal in shaping future research and therapeutic approaches, further reinforcing the global commitment to enhancing respiratory health and improving patient outcomes.
呼吸系统疾病在全球范围内构成了重大的公共卫生挑战，这需要基础研究人员和临床医生共同努力以找到有效的解决方案。中国受到广泛的呼吸系统疾病的严重影响，在这些疾病的研究和临床管理方面都取得了显著进展。举办国际呼吸医学（IRM）会议的主要目的是促进近期研究进展的交流，并推动中美科学家在基础和临床研究领域的合作。本文总结了在上海举行的IRM2024的关键见解，会议讨论了广泛的主题，包括肺组织发育、疾病机制和创新治疗策略。通过整合基础研究、转化研究和临床研究的观点，IRM2024突出了近期的进展，解决了持续存在的挑战，并探索了呼吸科学和临床实践的未来方向。从IRM2024获得的见解有望在塑造未来的研究和治疗方法方面发挥关键作用，进一步加强全球在改善呼吸健康和提高患者治疗效果方面的承诺。
